FREDERICK, Md., Dec. 17, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the expansion of its partnership with Betatek, Inc. ("Betatek"), transitioning the long term Canadian partner from an independent manufacturing representative to an official SteraMist distributor. This strategic move comes in response to the increasing demand for SteraMist in the Canadian market.

Betatek, a well-established Canadian partner, has been a valuable independent manufacturing representative for TOMI since 2017, successfully onboarding clients such as the University of Toronto Mississauga and CCRM, a cell and gene therapy organization. Betatek has become an official distributor after purchasing TOMI's latest product launch, the SteraMist Integrated System (SIS) Standalone. This partnership will enable TOMI to provide enhanced support and services to the Canadian life science market, with a focus on animal laboratory facilities. Betatek’s deep understanding of the local market, combined with TOMI’s advanced decontamination technologies, will deliver comprehensive solutions to address the growing demand from these facilities.

“We are thrilled to strengthen our partnership with Betatek,” said E.J. Shane, COO of TOMI Environmental Solutions. “Betatek’s expertise and dedication to customer satisfaction align seamlessly with TOMI’s mission and global growth strategy. This enhanced collaboration enables us to better serve the Canadian market, where demand for innovative disinfection solutions continues to grow.”

“Becoming an official distributor for TOMI is an exciting evolution of our partnership,” said Steve Goldenberg, President of Betatek, Inc. “With TOMI’s SteraMist technology, we can offer clients innovative and effective decontamination in high demand by the Canadian life science market and animal laboratories. We look forward to working closely with TOMI to provide exceptional service and support to our customers and ensure safety and compliance in their operations.”

About Betatek, Inc.

Betatek, Inc. is a Canadian-owned company that has been a trusted partner to the scientific community for over three decades. We specialize in providing high-quality laboratory equipment and services to pharmaceutical companies, university research institutions, and clinical laboratories. Our commitment to supporting local research and development, combined with our expertise and exceptional customer service, empowers researchers and scientists to achieve groundbreaking discoveries. For more information, please visit https://www.betatekinc.com/.

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.

For additional information, please visit http://www.steramist.com or contact us at This email address is being protected from spambots. You need JavaScript enabled to view it.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products to serve education sectors. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.